SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elena Crespo, Oriol Bestard, Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients, Clinical Biochemistry, 2015,

    CrossRef

  2. 2
    Chong Jai Kim, Roberto Romero, Piya Chaemsaithong, Jung-Sun Kim, Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance, American Journal of Obstetrics and Gynecology, 2015, 213, 4, S53

    CrossRef

  3. 3
    Patricia Hirt-Minkowski, Sacha A De Serres, Julie Ho, Developing renal allograft surveillance strategies – urinary biomarkers of cellular rejection, Canadian Journal of Kidney Health and Disease, 2015, 2, 1

    CrossRef

  4. 4
    Tom D. Blydt-Hansen, Ian W. Gibson, Ang Gao, Brenden Dufault, Julie Ho, Elevated Urinary CXCL10-to-Creatinine Ratio Is Associated With Subclinical and Clinical Rejection in Pediatric Renal Transplantation, Transplantation, 2015, 99, 4, 797

    CrossRef

  5. 5
    Song Ong, Roslyn B. Mannon, Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine, Transplantation Reviews, 2015, 29, 2, 60

    CrossRef

  6. 6
    Patricia Hirt-Minkowski, Julie Ho, Ang Gao, Patrizia Amico, Michael T. Koller, Helmut Hopfer, David N. Rush, Peter W. Nickerson, Stefan Schaub, Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels, Transplantation Direct, 2015, 1, 8, e31

    CrossRef

  7. 7
    David N. Rush, Ian W. Gibson, The perils of immunosuppression minimization, Current Opinion in Nephrology and Hypertension, 2015, 24, 6, 582

    CrossRef

  8. 8
    Stephan Schlickeiser, David Boës, Mathias Streitz, Birgit Sawitzki, The use of novel diagnostics to individualize immunosuppression following transplantation, Transplant International, 2015, 28, 8
  9. 9
    Julie Ho, David N. Rush, Peter W. Nickerson, Urinary biomarkers of renal transplant outcome, Current Opinion in Organ Transplantation, 2015, 20, 4, 476

    CrossRef

  10. 10
    Denise J. Lo, Bruce Kaplan, Allan D. Kirk, Biomarkers for kidney transplant rejection, Nature Reviews Nephrology, 2014, 10, 4, 215

    CrossRef

  11. 11
    Julie Ho, Chris Wiebe, Ian W. Gibson, Sabine Hombach-Klonisch, Ang Gao, Claudio Rigatto, Martin Karpinski, Leroy Storsley, Peter W. Nickerson, David N. Rush, Elevated Urinary CCL2, Transplantation, 2014, 98, 1, 39

    CrossRef

  12. 12
    Michael Mengel, Renalomics, Surgical Pathology Clinics, 2014, 7, 3, 443

    CrossRef

  13. 13
    Steven C. Kim, Eugenia K. Page, Stuart J. Knechtle, Urine proteomics in kidney transplantation, Transplantation Reviews, 2014, 28, 1, 15

    CrossRef

  14. 14
    Diane M. Cibrik, Roscoe L. Warner, Mallika Kommareddi, Peter Song, Fu L. Luan, Kent J. Johnson, Identification of a protein signature in renal allograft rejection, PROTEOMICS - Clinical Applications, 2013, 7, 11-12
  15. 15
    Natavudh Townamchai, Kassem Safa, Anil Chandraker, Immunologic monitoring in kidney transplant recipients, Kidney Research and Clinical Practice, 2013, 32, 2, 52

    CrossRef

  16. 16
    Julie Ho, Chris Wiebe, David N. Rush, Claudio Rigatto, Leroy Storsley, Martin Karpinski, Ang Gao, Ian W. Gibson, Peter W. Nickerson, Increased Urinary CCL2, Transplantation Journal, 2013, 95, 4, 595

    CrossRef

  17. 17
    D. E. Hricik, P. Nickerson, R. N. Formica, E. D. Poggio, D. Rush, K. A. Newell, J. Goebel, I. W. Gibson, R. L. Fairchild, M. Riggs, K. Spain, D. Ikle, N. D. Bridges, P. S. Heeger, Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury, American Journal of Transplantation, 2013, 13, 10
  18. 18
    W. Frank Peacock IV, Alan Maisel, Jieun Kim, Claudio Ronco, Neutrophil Gelatinase Associated Lipocalin in Acute Kidney Injury, Postgraduate Medicine, 2013, 125, 6, 82

    CrossRef

  19. 19
    Patricia Hirt-Minkowski, Michèle Roth, Gideon Hönger, Patrizia Amico, Helmut Hopfer, Stefan Schaub, Soluble CD30 correlates with clinical but not subclinical renal allograft rejection, Transplant International, 2013, 26, 1
  20. 20
    Xin ZHANG, Li-ming WANG, Biomarkers for long-term survival of renal graft: recent progress, Academic Journal of Second Military Medical University, 2012, 32, 2, 212

    CrossRef

  21. 21
    P. J. E. J. van de Berg, S. L. Yong, S. D. Koch, N. Lardy, K. A. M. I. van Donselaar-van der Pant, S. Florquin, F. J. Bemelman, R. A. W. van Lier, I. J. M. ten Berge, Characteristics of alloreactive T cells measured before renal transplantation, Clinical & Experimental Immunology, 2012, 168, 2
  22. 22
    Paola Romagnani, Clara Crescioli, CXCL10: A candidate biomarker in transplantation, Clinica Chimica Acta, 2012, 413, 17-18, 1364

    CrossRef

  23. 23
    P. Hirt-Minkowski, P. Amico, J. Ho, A. Gao, J. Bestland, H. Hopfer, J. Steiger, M. Dickenmann, F. Burkhalter, D. Rush, P. Nickerson, S. Schaub, Detection of Clinical and Subclinical Tubulo-Interstitial Inflammation by the Urinary CXCL10 Chemokine in a Real-Life Setting, American Journal of Transplantation, 2012, 12, 7
  24. 24
    Julie Ho, Chris Wiebe, Ian W. Gibson, David N. Rush, Peter W. Nickerson, Immune Monitoring of Kidney Allografts, American Journal of Kidney Diseases, 2012, 60, 4, 629

    CrossRef

  25. 25
    Tara K Sigdel, Xiaoxiao Gao, Minnie M Sarwal, Protein and peptide biomarkers in organ transplantation, Biomarkers in Medicine, 2012, 6, 3, 259

    CrossRef

  26. 26
    G. B. Piccoli, M. Ferraresi, E. Aroasio, S. Gonella, A. De Pascale, A. Veltri, The search for perfect biomarkers in acute kidney damage: the case of NGAL, from AKI to acute pyelonephritis: back to the clinic?, Nephrology Dialysis Transplantation, 2012, 27, 9, 3665

    CrossRef

  27. 27
    Silke Roedder, Matthew Vitalone, Purvesh Khatri, Minnie M Sarwal, Biomarkers in solid organ transplantation: establishing personalized transplantation medicine, Genome Medicine, 2011, 3, 6, 37

    CrossRef

  28. 28
    Youying Mao, Minmin Wang, Qin Zhou, Juan Jin, Yucheng Wang, Wenhan Peng, Jianyong Wu, Zhangfei Shou, Jianghua Chen, CXCL10 and CXCL13 Expression were Highly Up-regulated in Peripheral Blood Mononuclear Cells in Acute Rejection and Poor Response to Anti-Rejection Therapy, Journal of Clinical Immunology, 2011, 31, 3, 414

    CrossRef

  29. 29
    Birgit Sawitzki, Stephan Schlickeiser, Petra Reinke, Hans-Dieter Volk, Monitoring tolerance and rejection in organ transplant recipients, Biomarkers, 2011, 16, sup1, S42

    CrossRef

  30. 30
    Tara K. Sigdel, Sangho Lee, Minnie M. Sarwal, Profiling the proteome in renal transplantation, PROTEOMICS - Clinical Applications, 2011, 5, 5-6
  31. 31
    Bertram L. Kasiske, Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot?, American Journal of Kidney Diseases, 2011, 57, 5, 654

    CrossRef

  32. 32
    Tara K Sigdel, Minnie M Sarwal, Recent advances in biomarker discovery in solid organ transplant by proteomics, Expert Review of Proteomics, 2011, 8, 6, 705

    CrossRef

  33. 33
    J. A. Jackson, E. J. Kim, B. Begley, J. Cheeseman, T. Harden, S. D. Perez, S. Thomas, B. Warshaw, A. D. Kirk, Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection, American Journal of Transplantation, 2011, 11, 10
  34. 34
    Julie Ho, David N. Rush, Martin Karpinski, Leroy Storsley, Ian W. Gibson, Jennifer Bestland, Ang Gao, William Stefura, Kent T. HayGlass, Peter W. Nickerson, Validation of Urinary CXCL10 As a Marker of Borderline, Subclinical, and Clinical Tubulitis, Transplantation, 2011, 92, 8, 878

    CrossRef

  35. 35
    Kumiko Isse, Kedar Grama, Isaac Morse Abbott, Andrew Lesniak, John G. Lunz, William M.F. Lee, Susan Specht, Natasha Corbitt, Yoshiaki Mizuguchi, Badrinath Roysam, A.J. Demetris, Adding Value to Liver (and Allograft) Biopsy Evaluation Using a Combination of Multiplex Quantum Dot Immunostaining, High-Resolution Whole-Slide Digital Imaging, and Automated Image Analysis, Clinics in Liver Disease, 2010, 14, 4, 669

    CrossRef

  36. 36
    Julie Ho, David N. Rush, Ian W. Gibson, Martin Karpinski, Leroy Storsley, Jennifer Bestland, William Stefura, Kent T. HayGlass, Peter W. Nickerson, Early Urinary CCL2 is Associated With the Later Development of Interstitial Fibrosis and Tubular Atrophy in Renal Allografts, Transplantation, 2010, 90, 4, 394

    CrossRef

  37. 37
    Birgit Sawitzki, Petra Reinke, Andreas Pascher, Hans-Dieter Volk, State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression, Current Opinion in Organ Transplantation, 2010, 15, 6, 691

    CrossRef

  38. 38
    S. Marieke van Ham, Kirstin M. Heutinck, Tineke Jorritsma, Fréderike J. Bemelman, Merel C.M. Strik, Wim Vos, Jettie J.F. Muris, Sandrine Florquin, Ineke J.M. ten Berge, Ajda T. Rowshani, Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients, Kidney International, 2010, 78, 10, 1033

    CrossRef

  39. 39
    Peter Nickerson, Post-transplant monitoring of renal allografts: are we there yet?, Current Opinion in Immunology, 2009, 21, 5, 563

    CrossRef

  40. 40
    Oriol Bestard, Birgit Sawitzki, Alberto Sánchez-Fueyo, Biomarkers and Alloimmune Monitoring after Organ Transplantation,